Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "The Global Sol-Gel Coatings Market 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Global Sol-Gel Coatings Market 2025-2035 ...
Sol-Gel Technologies Ltd. has announced positive results for a Phase II trial in the U.S. targeting mild-to-severe rosacea using a benzoyl peroxide drug product developed by Sol-Gel. Although benzoyl ...
Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...
PreveCeutical Medical (OTCQB:PRVCF) said it granted Endosane Pharmaceuticals an option to license sol-gel technology for the delivery of cannabinoid products on an exclusive basis. The purpose of the ...
The dermatology company's unique wrapping method makes it possible to combine two anti-acne drugs. Dermatology company Sol-Gel is considering an IPO in the coming months at a $200-300 million company ...
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), is pleased to announce that it ...
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback